<DOC>
	<DOCNO>NCT01105169</DOCNO>
	<brief_summary>Colorectal cancer fourth common incident cancer second common cause cancer death United States , approximately 150,000 new case 57,000 death per year . High calcium intake magnesium may protect colorectal cancer adenoma , however , result inconsistent . We find genetic makeup , associate magnesium absorption re-absorption , significantly interacted calcium magnesium ratio relation adenomatous hyperplastic polyp . Participants carry least one 1482Ile allele ( G- &gt; A ) TRPM7 consume diet high calcium/magnesium ratio high risk adenoma hyperplastic polyp participant carry polymorphism . We hypothesize reduction dietary Ca/Mg ratio may change marker directly relate tumorigenesis . The primary aim study conduct randomize placebo-controlled intervention trial test whether reduce Ca/mg intake ratio magnesium supplementation effect related biomarkers . We also examine whether effect modulate Ca/Mg intake ratio may pronounce among carry 1482Ile allele compare n't carry 1482Ile allele . Results study help identify people high risk colorectal adenoma develop personalized strategy prevent occurrence colorectal adenoma , thus , colorectal cancer dietary change nutritional fortification .</brief_summary>
	<brief_title>Personalized Prevention Colorectal Cancer Trial</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Participants TCPS ( IRB # 090235 ) , TIARS ( IRB # 090235 ) , Vanderbilt University Hospital resource Consent contact future study TCPS ( IRB # 020462 ) , TIARS ( IRB # 090235 ) Participants calcium intake â‰¥ 700 mg/day measure 24 hour dietary recall Participants calcium intake &lt; 2000 mg/day measure 24 hour dietary recall Participants calcium/magnesium intake ratio &gt; 2.6 Participants know genotype Thr1482Ile polymorphism TRPM7 Will live Nashville surround area next 6 month Intolerance magnesium glycinate microcrystalline cellulose ( placebo ) Chronic renal disease hepatic cirrhosis Chronic ischemic heart disease unstable angina , chronic heart failure class III IV acute myocardial infarction last 6 month Chronic diarrhea Current breastfeeding Current plan pregnancy Type I diabetes mellitus Pituitary dwarfism Use digoxin licorice Current use blood anticoagulant drug Dicumarol ( Warfarin ) , Clopidogrel ( Plavix ) , Prasugrel HCl ( Efficent ) , Ticlopidine ( Ticlid ) , Lovenox ( Enoxaparin ) , Fragmin ( Dalteparin ) , Innohep ( Tinzaparin ) , Eptifibatide ( Integrilin ) , Tyrofiban ( Aggrastat ) , Abciximab ( Reopro ) Current use lithium carbonate therapy ( Eskalith , Lithobid , Lithonate , Lithotabs , ApoLithium carbonate , ApoLithium carbonate SR , Carbolth , Duralith , PMSLithium carbonate , PMSLithium citrate ) Individuals history colon resection colectomy due reason Individuals history cancer nonmelanoma skin cancer Individual history organ transplantation Individual history gastric bypass due reason Individuals Inflammatory bowel disease Individuals creatinine clearance &lt; 50 Currently institutionalize Homeless individual ( address , telephone etc . ) Unable provide inform consent Any condition opinion investigator raise concern protocol compliance</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Personalized prevention</keyword>
	<keyword>Colorectal cancer</keyword>
	<keyword>Investigational Nutrigenetic Studies</keyword>
	<keyword>Magnesium</keyword>
	<keyword>Gene polymorphism</keyword>
</DOC>